|

Lenbelintide Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: AZD6234

Pipeline

Phase 3: 3

Top Sponsors

  • AstraZeneca3

Indications

  • Obesity or Overweight3
  • Diabetes3
  • With/Without Diabetes Mellitus, Type 21
  • Weight-Related Comorbidity1
  • Diabetes Mellitus, Type 21

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.